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Background and purpose — There has been a recent trend 
towards the use of greater femoral head sizes in an attempt to 
improve function and enhance stability after primary hip replace-
ment. This has been associated with the use of alternative bear-
ings, theoretically to reduce wear and improve implant longevity.
Methods — We examined the influence of these variables on 
patient-reported outcome measures (PROMs) for a consecutive 
series of primary hip replacements using National Joint Regis-
try (NJR) and PROMs-linked data. To minimize the confound-
ing influence of implant design factors, the single most commonly 
used brand in England and Wales (DePuy Corail Pinnacle) was 
examined. Improvement in patient hip-specific outcomes (Oxford 
hip score, OHS), general health outcomes (Euroqol, EQ-5D), and 
rates of self-reported complications (bleeding, wound problems, re-
admission, and reoperation) were compared for different head sizes 
(28-mm, 32-mm, and 36-mm) and bearings (metal-on-polyethylene 
(MoP), ceramic-on-polyethylene (CoP), and ceramic-on-ceramic 
(CoC)), adjusting for differences in case mix. 
Results — At a mean follow-up of 7 months, improvements in 
OHS and EQ5D index were similar for 28-mm and 36-mm heads. 
A 32-mm head was associated with poorer function (OHS: 20, 
99% CI: 19–21, p = 0.002; EQ5D index: 0.39, 99% CI: 0.36–0.42, 
p = 0.004), although these small differences may not be of clini-
cal importance. There were no statistically significant benefits of 
either CoP or CoC bearings compared to a MoP bearing.  Com-
plication rates were similar within comparisons of head sizes or 
bearings.
Interpretation — In this short-term study, we did not find 
any functional benefits of larger head sizes or alternative bear-
ings, after adjusting for other influences. We question their use 
in routine primary hip replacement given the lack of evidence of 
improved long-term survival in the literature.

Greater femoral head size may improve function and enhance 
stability after primary total hip replacement (THR) (Bartz et 
al. 2000, Cuckler et al. 2004, Hummel et al. 2009). Previous 
studies have shown a greater range of movement with increas-
ing head size (Amstutz et al. 1975, Matsushita et al. 2009). 
Use of a larger head size is an attractive option in younger 
patients who require stability at higher levels of function, and 
in older patients in order to reduce dislocation risk. However, 
greater surface area may also increase wear rates, irrespec-
tive of bearing materials (Charnley et al. 1969, Dowling et al. 
1978, Livermore et al. 1990, Bragdon et al. 2013, Jack et al. 
2013), and there have been reports of excessive taper load with 
large-diameter bearings (Langton et al. 2012, Meyer et al. 
2012). Larger heads have been associated with the use of alter-
native bearings, in order to reduce wear and improve implant 
longevity. The National Joint Registry (NJR) in England and 
Wales has described an increase in the use of larger femoral 
head sizes (over 28 mm)—from 5% to 50% between 2005 and 
2010 (England and Wales National Joint Registry 2012). Over 
the same period, the use of ceramic-on-polyethylene (CoP) 
and ceramic-on-ceramic (CoC) bearings has increased.  
Medium-term revision rates are higher with CoC bearings 
than with metal-on-polyethylene (MoP) bearings generally, 
across registry data, and specifically, when the most com-
monly used implant in England and Wales (Corail stem/Pin-
nacle cup; DePuy Ltd., Leeds, UK) was analyzed (Sexton et 
al. 2009, Jameson et al. 2013). Larger femoral sizes using 
hard-bearing technology did not give any functional improve-
ment over 28-mm MoP (Hanna et al. 2012) in a small random-
ized trial, and larger head sizes have not been found to offer 
any gait-related benefits (Zagra et al. 2013). The functional 
benefits of increasing head size and alternative bearings have 
yet to fully assessed.
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with the corresponding demographic and operative details 
held in the NJR. To link them, a number of criteria were used: 
firstly, to ensure correct matching, 2 unique identifiers (NJR 
and procedure numbers) recorded in both datasets were used; 
secondly, the operation date recorded by the patient in the 
PROMs data had to be within ± 30 days of the operation date 
recorded on the NJR record, to ensure that the patient was 
scoring the same procedure.    
We chose to perform the analysis using the single most com-
monly used brand of THR used in England and Wales (Corail 
stem/Pinnacle cup; DePuy Ltd., Leeds, UK), in order to con-
trol for any implant-related influences (England and Wales 
National Joint Registry 2012). 
There were a number of exclusion criteria.  For the NJR 
data, these were: all procedures with an indication other than 
OA, procedures with missing implant or patient data, head 
sizes smaller than 28 mm and larger than 36 mm, and rarely 
used bearings (ceramic-on-metal and metal-on-ceramic). 
Metal-on-metal bearings were also excluded, as few of these 
are now implanted (England and Wales National Joint Reg-
istry 2012). Procedures with PROMs data that were missing, 
undated, dated more than 12 months prior to or following the 
operation, or that had non-identical duplicates were excluded; 
for identical duplicates, the first record was retained for analy-
sis. Where the presence of a co-morbidity or complication was 
asked for in the questionnaire but left blank by the patient, it 
was assumed to be absent.  The study population is summa-
rized in Figure 1. The PROMs project was introduced in April 
2008. Linkage of NJR data to PROMs was possible between 
this date and December 2010 (the limit of our access to NJR 
data). Details regarding the delivery and return of PROMs 
questionnaires were not available for this study. The demo-
graphic, surgical, and implant-related variables available for 
analysis are listed in Table 1 (see Supplementary data).  
The national PROMs project uses validated measures of 
hip-specific outcomes (Oxford hip score (OHS)) (Dawson et 
al. 1996) and general health outcomes (EuroQol (EQ-5D)) 
(EuroQol group 2009). For this analysis, the outcomes of 
interest were improvements between preoperative and postop-
erative scores (the “change scores”) and self-reported postop-
erative complications (bleeding, wound problems, re-admis-
sion, and reoperation). Change scores, being approximately 
normally distributed, are analytically preferable to postopera-
tive scores (Browne et al. 2007). The OHS (score 0–48) has 
Primary hip replacements with pre-
and postoperative patient reported
outcome measures (PROMs)
n = 85,215
Hip replacements performed for
osteoarthritis using the cementless
DePuy Corail stem and Pinnacle cup
n = 6,827
EXCLUDED: n = 2,231
– invalid PROMs data a (1,484)
– head sizes other than 28, 32 or
   36 mm (60)
– bearings other than MoP, CoP 
   or CoC (687)
Population studied
n = 4,596
No linkage data available
n = 28,417
NJR–PROMs linked records
n = 56,789
Primary hip replacements 
with complete patient data 
submitted to the National 
Joint Registry (NJR) database
and performed 
between April 2008 and 
December 31, 2010
n = 179,735
Figure 1. Flow chart describing the study cohort. MoP – metal-on-polyethylene, CoP – 
ceramic-on-polyethylene, CoC –ceramic-on-ceramic. a Invalid PROMs data includes 
records with missing outcome score rccords, preoperative scores dated more than 12 
months prior to operation, postoperative records without a date or dated < 6 months 
or > 12 months following the primary hip replacement, non-identical duplicates (all 
excluded) and identical duplicates (only one record retained). 
Patient-reported outcome measures (PROMs) 
supplement revision risk in the assessment of suc-
cess after joint replacement (Devlin et al. 2010). 
PROMs are routinely collected on National Health 
Service (NHS) patients undergoing THR in Eng-
land. Data on hip replacement patients, their sur-
geons, and the implants used are collected by the 
NJR. These datasets can be linked in order to 
compare early outcomes for specific patient and 
implant groups at the national level. The present 
analysis explored the effect of bearing surface and 
femoral head size on PROMs and complications 
following THR. We hypothesized that larger heads 
and alternative bearings would have no functional 
benefit over standard (28-mm MoP) bearings.
material and methods
Design
We conducted a cohort study using prospectively 
collected patient-level NJR and PROMs-linked 
data to compare outcome scores and self-reported 
complications after primary THR for different 
head sizes and different bearings.  
Data
The national PROMs study collects joint-spe-
cific and general health scores preoperatively 
and around 6 months postoperatively, and self-
reported complications. By linking databases at 
the patient level, PROMs data can be combined 
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previously been shown to be a reliable, valid, and responsive 
outcome measure (Murray et al. 2007). A threshold of 3 points 
has been proposed to demonstrate a clinically important dif-
ference (Murray et al. 2007). The EQ-5D index (score –0.59 
to 1.00) is a generic measure of health used for clinical and 
economic appraisal. It evaluates 5 different aspects of gen-
eral health (mobility, self-care, usual activities, pain/discom-
fort, and anxiety/depression) that are scored and combined 
using population weightings to produce a single index value 
for health status (group 2009). Patients are also asked about 
comorbidities, general health, and self-reported disability as 
part of the preoperative PROMs questionnaire. These can be 
used to adjust for differences in health status between patient 
groups. Sample sizes for all the head-size and bearing groups 
were in excess of the minimum numbers identified in the 
PROMs feasibility pilot for identification of meaningful dif-
ferences (more than 150 per group) (Browne et al. 2007).
Patients are also asked to indicate their satisfaction with the 
outcome following surgery (excellent, very good, good, fair, or 
poor), and whether they deem surgery to have been a success 
(much better, a little better, about the same, a little worse, or 
much worse). While unadjusted values have been provided for 
information, no attempt was made to adjust for baseline dif-
ferences in either success or satisfaction, as previous analyses 
have demonstrated that the variables available within the NJR 
and PROMs databases are insufficient to explain these differ-
ences (i.e. the influence of unmeasured variables has a greater 
effect than the effect of the measured variables) (Browne et al. 
2007, Hamilton et al. 2013).
Statistics
The variables available for the analyses are shown in Table 1 
(see Supplementary data). The head sizes analyzed were 28 
mm, 32 mm, and 36 mm. The bearings were MoP, CoP, and 
CoC. Differences in baseline characteristics across the groups 
would be a source of confounding in any comparative analy-
sis. Thus, to test the hypothesis that there were no differences 
between groups, the following tests were employed: 1-way 
analysis of variance (ANOVA, parametric continuous data vari-
ables), the Kruskal-Wallis test (non-parametric continuous data 
variables), or the chi-square test (categorical data variables). 
Univariable analysis was performed initially to identify 
variables that possibly influenced each outcome, based on 
statistical rejection criteria of p > 0.1; these variables were 
then included in the multivariable models. Analysis of covari-
ance (ANCOVA) was used for testing of differences in OHS 
and EQ5D index change scores across head size and bearing 
groups. Multivariable logistic regression was used to analyze 
differences in the risk of each of the complications across 
groups. Time from implantation to questionnaire completion 
was included in models to evaluate whether differences in 
duration of follow-up influenced findings. Preoperative scores 
were included in all models, as recommended by the designers 
of the Oxford hip score (Murray et al. 2007). 
Reflecting analysis of a large dataset, statistical models 
for the change scores were evaluated with the margins func-
tion in STATA in order to provide predicted values (includ-
ing 99% confidence intervals (CIs)) separately for each of the 
head-size and bearing categories. p-values are provided as 
statistical evaluation of the differences between the reference 
(head size of 28 mm and MoP bearing) and other variables 
within the category. For complication risks, results are pre-
sented as odds ratios (ORs) with CIs: ratios greater than 1 
indicate that risk is higher when compared with the reference 
category. Due to the statistical methods employed and the 
large population size, only covariates fitting models with p < 
0.01 were retained in final models as significant influences, to 
reduce the risk of type-1 error. All models were fitted using 
STATA 12. 
For more information on the statistical techniques used, see 
Supplementary data.
Ethics
Explicit patient consent was taken for both the NJR and 
PROMs data collection. Further ethics approval is not required 
for registry studies in the UK.
results
There were 4,596 NJR-PROMs linked primary procedures. 
MoP accounted for 47% (2,171), CoC for 45% (2,064), and 
CoP for 7.9% (361). A standard (28-mm) head size was used 
in 41% of procedures (1,864), the 36-mm in 41% (1,863), and 
the 32-mm in 19% (869). When the demographics were com-
pared across bearing groups, patients with a CoC bearing were 
generally younger and in better health, but there were compa-
rable numbers of women in each group and mean BMI was 
similar. Patients who had a larger head size implanted were 
generally younger and in better health (Table 2). Patients fitted 
with a 32-mm head generally had a higher ASA grade and 
higher BMI, and poorer general health. Although there were 
statistically significant differences between categories of bear-
ing and head size for each of the surgical covariates as a result 
of the large study population, the groups were qualitatively 
similar and therefore broadly comparable (Tables 2 and 3).
In the unadjusted PROMs data, patients with a CoC bearing 
and a larger head size generally had higher preoperative and 
postoperative OHS and EQ5D indices. Patient-reported levels 
of satisfaction and success were similar across the bearing 
groups and the 28-mm and 36-mm head size groups, although 
the 32-mm head size group had poorer scores (Tables 4 and 5). 
Improvement in outcome score
Improvements in OHS and EQ5D index were similar for MoP, 
CoP, and CoC bearings (Table 6, see Supplementary data).
Improvements in OHS and EQ5D index were similar for a 
28-mm and a 36-mm head. Although the difference was small, 
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the 32-mm head was associated with a poorer outcome (OHS: 
20, 99% CI: 19–21, p = 0.002; EQ5D index: 0.39, 99% CI: 
0.36–0.42, p = 0.004) (Table 7, see Supplementary data). 
Risk of complications
There were no statistically significant differences in risk of 
Table 2. Patient demographics for the population studied, by head size
    Head size  
  All patients 28 mm (Reference) 32 mm 36 mm p-value a
Number (%) 4,596 1,864  (40.6)  869  (18.9) 1,863  (40.5)
Patient factors     
 Age, mean (SD) range 66.0 (9.7) 25.2–95.1 68.0 (8.9) 31.0–95.1  68.2 (10.1) 26.2– 94.1 62.9 (9.5) 25.2–90.2 < 0.001
 Females, n (%)  2,620 (57.0) 1,303  (69.9)  535  (61.6)    782  (42.0) < 0.001
 ASA, n (%)     < 0.001
    1    804  (17.5)    286  (15.3)    93  (10.7)    425  (22.8) 
    2 3,360  (73.1) 1,410  (75.6)  644  (74.1) 1,306  (70.1) 
    3+    432  (9.4)    168  (9.0)  132  (15.2)    132  (7.1) 
 BMI (SD) range b   29.0  (5.4) 15–65   28.7  (5.2) 15–56 29.1  (5.6) 16–50   29.5  (5.4) 16–65 0.03
 Comorbidities, n (%)     
    Heart disease    388  (8.4)    152  (8.2)    91  (10.5)    145  (7.8) 0.05
    Stroke      67  (1.5)      29  (1.6)    13  (1.5)      25  (1.3) 0.9
    Diabetes    355  (7.7)    158  (8.5)    70  (8.1)    127  (6.8) 0.2
    Hypertension 1,764  (38.4)    739  (39.7)  366  (42.1)    659  (35.4) 0.001
    Circulation    221  (4.8)    102  (5.5)    45  (5.2)      74  (4.0) 0.09
    Lung    270  (5.9)    112  (6.0)    42  (4.8)    116  (6.2) 0.3
    Depression    309  (6.7)    126  (6.8)    44  (5.1)    139  (6.7) 0.07
 Preoperative general health     0.02
    Excellent    265  (5.8)    100  (5.4)    53  (6.1)    114  (6.1) 
    Very good 1,413  (30.7)    566  (30.4)  235  (27.0)    611  (32.8) 
    Good 2,008  (43.7)    862  (46.2)  394  (45.3)    755  (40.5) 
    Fair    781  (17.0)    285  (15.3)  165  (19.0)    330  (17.7) 
    Poor    129  (2.9)      51  (2.7)    22  (2.5)      53  (2.8) 
 Preoperative disability 2,229  (48.5)    928  (50.0)  448  (51.6)    853  (45.8) 0.007
Surgical factors     
 Chemical VTE prophylaxis     < 0.001
    LMWH only 2,583  (56.2) 1,115  (59.8)  518  (59.6)    950  (51.0) 
    Aspirin only    415  (9.0)    146  (7.8)    50  (5.8)    219  (11.8) 
    Other    544  (11.8)    163  (8.7)    98  (11.3)    283  (15.2) 
    None    304  (6.6)    133  (7.1)    36  (4.1)    135  (7.3) 
    Not recorded    750  (16.3)    307  (16.5)  167  (19.2)    276  (14.8) 
 Mechanical VTE prophylaxis     < 0.001
    Compression stockings (CS) 1,249  (27.2)    500  (26.8)  222  (25.6)    527  (28.3) 
    CS + mechanical pump    918  (20.0)    296  (15.9)  134  (15.4)    488  (26.2) 
    Foot pump only    523  (11.4)    278  (14.9)    86  (9.9)    159  (8.5) 
    Mechanical calf pump only    756  (16.5)    312  (16.7)  173  (19.9)    271  (14.6) 
    Other      22  (0.5)        7  (0.4)      0  (0.0)      15  (1.0) 
    None    378  (8.2)    164  (8.8)    87  (6.8)    127  (6.8) 
    Not recorded    750  (16.3)    307  (16.5)  167  (19.2)    276  (14.8) 
 Bearing     < 0.001
    Metal-on-polyethylene 2,171  (47.2) 1,423  (76.3)  510  (58.7)    238  (12.8) 
    Ceramic-on-polyethylene    361  (7.9)    198  (10.6)  100  (11.5)      63  (3.4) 
    Ceramic-on-ceramic 2,064  (44.9)    243  (13.0)  259  (29.8) 1,562  (83.8) 
 Anesthesia     < 0.001
    Regional 2,077  (45.2)    871  (46.7)  303  (34.9)    903  (48.5) 
    General    827  (18.0)    312  (16.7)  168  (19.3)    347  (18.6) 
    Regional and general    906  (19.7)    357  (19.2)  224  (25.8)    325  (17.4) 
    Not recorded    786  (17.1)    324  (17.4)  174  (20.0)    288  (15.5) 
 Lead surgeon grade     < 0.001
    Consultant 3,475  (75.6) 1,484  (79.6)  618  (71.1) 1,373  (73.7) 
    Other 1,121  (24.4)    380  (20.4)  251  (28.9)    490  (26.3) 
 Position      0.02
    Lateral 3,598  (78.3) 1,449  (77.7)  666  (76.6) 1,483  (79.6) 
    Supine    248  (5.4)    108  (5.8)    36  (4.1)    104  (5.6) 
    Not recorded    750  (16.3)    307  (16.5)  167  (19.2)    276  (14.8) 
ASA: American Society of Anaesthesiologists score; PROMs: patient-reported outcomes measures.
a Difference between groups with 1-way ANOVA (continuous data variables) or chi-squared test (categorical data variables). 
b
 BMI (body mass index) data on 2,726.
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bleeding, wound complications, re-admission, or reoperation 
after case-mix adjustment when the bearing groups were com-
pared (Table 8, see Supplementary data). Bleeding risk was 
higher in the 32-mm head-size group (OR = 1.8, 99% CI: 1.2–
2.8, p < 0.001) but not in the 36-mm head-size group (OR 1.3, 
CI 0.9 to 2.0, 0.063) when compared with the 28-mm group. 
Table 3. Patient demographics for the population studied, by bearing
    Bearing  
   Metal-on- Ceramic-on- Ceramic-on-
  All patients polyethylene (Reference) polyethylene ceramic p-value a
Number (%) 4,596  2,171 (47.2)   361 (7.9)  2,064 (44.9)
Patient factors     
 Age, mean (SD) range 66.0 (9.7) 25.2–95.1 70.8 (8.0) 31.0–95.1 64.6 (8.3) 39.0–87.2 61.1 (9.1) 25.2–91.5 < 0.001
 Females, n (%)  2,620 (57.0) 1,259  (58.0)  220  (60.9) 1,141  (55.3) 0.06
 ASA, n (%)     < 0.001
    1    804  (17.5)    246  (11.3)    64  (17.7)    494  (23.9) 
    2 3,360  (73.1) 1,673  (77.1)  249  (69.0) 1,438  (69.7) 
    3+    432  (9.4)    252  (11.6)    48  (13.3)    132  (6.4) 
 BMI (SD) range b   29.0  (5.4) 15–65   28.7  (5.2) 15–56 29.3  (5.3) 18–54   29.2  (5.6) 18–65 0.09
 Comorbidities, n (%)     
    Heart disease    388  (8.4)    233  (10.7)    28  (7.8)    127  (6.2) < 0.001
    Stroke      67  (1.5)      42  (1.9)      4  (1.1)      21  (1.0) 0.04
    Diabetes    355  (7.7)    201  (9.3)    27  (7.5)    127  (6.2) 0.001
    Hypertension 1,764  (38.4)    960  (44.2)  136  (37.7)    668  (32.4) < 0.001
    Circulation    221  (4.8)    132  (6.1)    25  (6.9)      64  (3.1) < 0.001
    Lung    270  (5.9)    122  (5.6)    21  (5.8)    127  (6.2) 0.8
    Depression    309  (6.7)    123  (5.7)    25  (6.9)    161  (7.8) 0.02
 Preoperative general health     0.001
    Excellent    265  (5.8)    104  (4.8)    20  (5.5)    137  (6.6) 
    Very good 1,413  (30.7)    649  (29.9)    93  (25.8)    669  (32.4) 
    Good 2,008  (43.7) 1,004  (46.2)  184  (51.0)    819  (39.7) 
    Fair    781  (17.0)    363  (16.7)    53  (14.7)    380  (18.4) 
    Poor    129  (2.9)      51  (2.3)    11  (3.0)      59  (2.9) 
 Preoperative disability 2,229  (48.5) 1,117  (51.5)  192  (53.2)    920  (44.6) < 0.001
Surgical factors     
 Chemical VTE prophylaxis     < 0.001
    LMWH only 2,583  (56.2) 1,322  (60.9)  211  (49.0) 1,050  (50.9) 
    Aspirin only    415    (9.0)    179  (8.3)    21  (5.8)    215  (10.4) 
    Other    544  (11.8)    189  (8.7)    45  (12.5)    310  (15.0) 
    None    304    (6.6)    115  (5.3)    27  (7.5)      62   (7.8) 
    Not recorded    750  (16.3)    366  (16.9)    57  (15.8)    327 (15.8) 
 Mechanical VTE prophylaxis     < 0.001
    Compression stockings (CS) 1,249  (27.2)    644  (29.7)    98  (27.2)    507  (24.6) 
    CS + mechanical pump    918  (20.0)    342  (15.8)    79  (21.9)    497  (24.1) 
    Foot pump only    523  (11.4)    324  (14.9)    10  (2.8)    189  (9.2) 
    Mechanical calf pump only    756  (16.5)    311  (14.3)    70  (19.4)    375  (18.2) 
    Other      22  (0.5)        4  (0.2)      1  (0.3)      17  (0.8) 
    None    378  (8.2)    180  (8.3)    46  (12.7)    152  (7.4) 
    Not recorded    750  (16.3)    366  (16.9)    57  (15.8)    327  (15.4) 
 Head size     < 0.001
    28 mm 1,864  (40.6) 1,423  (65.6)  198  (54.9)    243  (11.8) 
    32 mm    869  (18.9)    510  (23.5)  100  (27.7)    869  (18.9) 
    36 mm 1,863  (40.5)    238  (11.0)    63  (17.5) 1,562  (40.5) 
 Anesthesia     0.01
    Regional 2,077  (45.2)    987  (45.5)  153  (42.4)    937  (45.4) 
    General    827  (18.0)    344  (15.9)    72  (19.9)    411  (19.9) 
    Regional and general    906  (19.7)    454  (20.9)    77  (18.2)    375  (18.2) 
    Not recorded    786  (17.1)    386  (17.8)    59  (16.3)    341  (16.5) 
 Lead surgeon grade     0.002
    Consultant 3,475  (75.6) 1,600  (73.7)  294  (81.4) 1,581  (76.6) 
    Other 1,121  (24.4)    571  (26.3)    67  (18.6)    483  (23.4) 
 Position      0.1
    Lateral 3,598  (78.3) 1,708  (78.7)  284  (78.7) 1,606  (77.8) 
    Supine    248    (5.4)      97  (4.5)    20  (5.5)    131  (6.4) 
    Not recorded    750  (16.3)    366  (16.9)    57  (15.8)    327  (15.8) 
ASA: American Society of Anaesthesiologists score; PROMs: patient-reported outcomes measures.
a Difference between groups with 1-way ANOVA (continuous data variables) or chi-squared test (categorical data variables). 
b
 BMI (body mass index) data on 2,726.
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Risk of wound complications was higher in the 36-mm group 
(OR = 1.7, 99% CI: 1.1–2.6, p = 0.002). Re-admission and 
reoperation risks were similar when the different head sizes 
were compared (Table 9, see Supplementary data). 
Discussion
This large cohort study using NJR-PROMs linked data from a 
single hip system showed no functional benefit when femoral 
Table 4. Patient-reported outcomes for populations studied, by bearing
 Metal-on-polyethylene Ceramic-on-polyethylene Ceramic-on-ceramic p-value a
Number (%) 2,171 (47.2) 361 (7.9) 2,064 (44.9) 
Oxford hip score    
     Preoperative, mean (SD) range 18.4 (8.0) 1–43 18.5 (8.4) 0–43 19.2 (8.1) 1–46 0.003
     Postoperative, median (range) 42 (0–48) 41 (7–48) 43 (2–48) < 0.001
EQ5D index    
 Preoperative, mean (SD)  0.368 (0.314) 0.375 (0.331) 0.394 (0.311) 0.01
    range -0.349 to 1 -0.484 to 0.883 -0.594 to 1 
    Postoperative, median (range) 0.815 (-0.319 to 1) 0.796 (-0.319 to 1) 0.848 (-0.594 to 1) 0.008
Satisfaction, n (%)    0.3
 Excellent    882  (40.6) 144  (39.9)    887  (43.0) 
 Very good    804  (37.0) 123  (34.1)    728  (35.3) 
 Good    364  (16.8)   66  (18.3)    321  (15.6) 
 Fair      90  (4.2)   23    (6.4)      89  (4.3) 
 Poor      31  (1.4)     5    (1.4)      39  (1.9) 
Success, n (%)    0.05
 Much better 1,936  (89.2) 303  (83.9) 1,828  (88.6) 
 A little better    157  (7.2)   46  (12.7)    158  (7.7) 
 About the same      33  (1.5)     3  (0.8)      35  (1.7) 
 A little worse      26  (1.2)     6  (1.7)      29  (1.4) 
 Much worse      19  (0.9)     3  (0.8)      14  (0.7) 
Time from operation to PROMs completion, 
 mean days (SD) range 208 (28) 183–363 207 (23) 183–333 210 (29) 183–361 0.002
PROMs: patient-reported outcome measures.
a 1-way ANOVA was used for parametric data, Kruskal-Wallis test for non-parametric data, and chi-squared test for proportions.
Table 5. Patient-reported outcomes for populations studied, by head size
 28 mm 32 mm 36 mm p-value a
Number (%) 1,864  (40.6) 869  (18.9) 1,863  (40.5) 
Oxford hip score    
     Preoperative, mean (SD) range 18.2 (8.0) 1–44 18.3 (7.9) 2–43 19.6 (8.2) 0–46 < 0.001
     Postoperative, median (range) 43 (0–48) 41 (4–48) 48 (2–48) < 0.001
EQ5D index    
 Preoperative, mean (SD)  0.366 (0.315) 0.365 (0.316) 0.401 (0.311) 0.001
    range -0.484 to 1 -0.319 to 1 -0.594 to 1 
    Postoperative, median (range) 0.848 (-0.319 to 1) 0.796 (-0.126 to 1) 0.850 (-0.594 to 1) < 0.001
Satisfaction, n (%)    < 0.001
 Excellent    791  (42.4) 319  (36.7)    803  (43.1) 
 Very good    683  (36.6) 299  (34.4)    673  (36.1) 
 Good    288  (15.5) 190  (21.9)    273  (14.7) 
 Fair      77  (4.1)   46  (5.3)      79  (4.2) 
 Poor      25  (1.3)   15  (1.7)      35  (1.9) 
Success, n (%)    0.001
 Much better 1,673  (89.8) 736  (84.7) 1,658  (89.0) 
 A little better    124  (6.7) 103  (11.9)    134  (7.2) 
 About the same      27  (1.5)   14  (1.6)      30  (1.6) 
 A little worse      22  (1.2)   10  (1.2)      29  (1.6) 
 Much worse      18  (1.0)     6  (0.7)      12  (0.6) 
Time from operation to PROMs completion, 
 mean days (SD) range 207 (26) 183–361 209 (28) 184–357 210 (29) 183–363 0.002
PROMs: patient-reported outcome measures.
a 1-way ANOVA was used for parametric data, Kruskal-Wallis test for non-parametric data, and chi-squared test for proportions.
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head sizes greater than 28 mm and bearings other than MoP 
were used for primary THR. These findings are important 
for clinicians attempting to determine the most suitable hip 
implants for patients with osteoarthritis. 
While this is the largest study to date to report the effects of 
head size and bearing type on functional outcome for a single 
hip replacement brand, there are some potential limitations 
to our findings. The study design was observational and thus 
vulnerable to omitted variables, which may have confounded 
the findings. Some data were unavailable for analysis; for 
example, radiological data on cup positioning. There were 
also large numbers of procedures that could not be analyzed, 
either because the datasets could not be linked (for example, 
due to missing patient identification details) or because there 
were specific data fields with incomplete data. Moreover, any 
bias in completion and return of PROMs cannot be assessed, 
as no details were available regarding the number of question-
naires sent out or returned.  Non-responders are more likely 
to be younger patients (and therefore more likely to have 
larger head sizes and alternative bearings). However, previous 
PROMs analyses have demonstrated that non-responders gen-
erally perform more poorly (Ostendorf et al. 2004).  Irrespec-
tive of these issues, similarities between the unadjusted and 
adjusted models and robustness under different model fitting 
assumptions support the stability of estimates.
By restricting the implants to the most commonly used 
brand only, we were able to remove the problems associated 
with adjusting for multiple brands (differing implant design 
characteristics and bearing surface manufacturing processes). 
The Corail Pinnacle constitutes 14% of all hip implants used 
in England and Wales since 2003. Cementless components 
now predominate, and around 40% of those implanted in 
2011 were Corail Pinnacle (England-and-Wales-National-
Joint-Registry 2012). [Ann-Britt: v.v. ta bort bindestrecken] 
This implant combination also offers a wide range of bearing 
options and head sizes, making it a good choice for analysis, 
and sample sizes of each of the comparison groups were in 
excess of the minimum numbers required to identify meaning-
ful differences (Browne et al. 2007).  False-negative results 
are therefore unlikely, especially as OHS and EQ5D indices 
for each of the groups were qualitatively similar, irrespective 
of confidence intervals. 
As with all NJR-PROMs studies, the design of the study 
was constrained by the data available. In particular, this lim-
ited the length of follow-up available and the measures of hip 
function used. Although functional outcome at 6 months can 
be described as early, the follow-up in this study was adequate 
for group comparisons. The literature shows little improve-
ment in change in OHS between 6 months and 5 years follow-
ing hip replacement, suggesting that the results in our short-
term study are a reliable indication of longer-term outcome 
(Andrew et al. 2008, Judge et al. 2013).
Greater femoral head size may reduce dislocation risk. In 
a randomized trial of patients undergoing metal-on-highly-
crosslinked polyethylene hip replacements, Howie et al. 
(2012) found that a head size of 36 mm reduced the 1-year 
dislocation risk compared to 28 mm in 533 primary proce-
dures—from 4.4% to 0.8%. In addition, a large cohort study 
of over 240,000 THRs performed in England and Wales found 
a reduction in 1-year dislocation risk from 1.4% to 1.1% over 
a period of 5 years, during which the use of large femoral 
head sizes increased. However, there was no change in the 
12-month revision rate (Jameson et al. 2011). Lower dislo-
cation rates with larger femoral head sizes have also been 
found in Australian and Norwegian registry data (Bystrom et 
al. 2003, ANJRR 2013). Without radiographic data, disloca-
tion risk is difficult to analyze. The 1-year risk in the study 
by Howie et al. (2012) is high compared to others; Stroh et al. 
(2013) reported dislocation with head sizes less than 36 mm 
of only 1.8% (10 in 559) at 5 years, which is similar to the 
English NHS data  (taking into account that most dislocations 
occur in the first year after surgery) (Jameson et al. 2011). 
Before larger head sizes are recommended, the incidence of 
late dislocation, wear, periprosthetic osteolysis, and liner frac-
ture should also be established (Howie et al. 2012). Impor-
tantly, revision risk did not decrease in the English NHS data, 
suggesting that most early dislocations are relatively benign 
and do not require a revision procedure. Although dislocation 
data were unavailable in the current study, other outcomes 
were used as surrogate endpoints. The majority of dislocations 
following primary THR occur within the first 5 weeks after 
surgery (Bourne and Mehin 2004); therefore, patient-reported 
complications associated with a dislocation, such as re-admis-
sion and reoperation, should demonstrate a difference if, for 
example, one head size had a lower risk than another. Increas-
ing femoral head size may also increase range of movement, 
but several studies have shown that it is the patient’s bony 
anatomy that causes impingement, and therefore limits this 
range irrespective of head size (Bunn et al. 2012, Klingenstein 
et al. 2012). Interestingly, PROMs were poorer and bleeding 
risk was higher in patients implanted with a 32-mm head. This 
may be explained by the patient demographics, which showed 
a slightly greater mean BMI and relatively more patients 
with higher ASA grade and poorer health. In these patients, 
a surgeon may choose to increase head size from 28 mm in 
an attempt to increase stability, thereby potentially reducing a 
need for further revision surgery.  Differences in unmeasured 
patient variables across groups (which cannot be controlled) 
may also account for this finding. However, it must be stressed 
that the statistically significant OHS change difference of 1.4 
between 28-mm and 32-mm femoral heads is unlikely to be 
clinically significant.
Medium- to long-term risk of revision is lowest in MoP bear-
ings across worldwide registries and published trials, and no 
functional benefit of alternative bearings has so far been found 
(Sedrakyan et al. 2011). When implant survival of 35,386 
Corail Pinnacle THRs was examined in the NJR cohort, hard 
bearings had a higher revision risk than MoP (MoM: HR = 
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1.9, p < 0.001; CoC: HR = 1.6, p = 0.003) (Jameson et al. 
2013). In a randomized trial of 49 patients who received either 
large-head MoM articulations or standard (28- to 32-mm) 
MoP THRs, no statistically significant benefits were found in 
function, dislocation, or implant failure (Hanna et al. 2012), 
although the numbers are small and this could be a conse-
quence of type-II statistical error.
Metal-on-metal bearings were not included in this study. 
Although a large number of Corail Pinnacle THRs have been 
implanted in England and Wales with these bearings, their use 
is now low due to high revision rates and concerns regarding 
the systemic effects of excessive metal wear debris.  
In summary, no functional benefits of larger head sizes or 
alternative bearings were found in this national analysis of 
NJR-PROMs linked THRs, after adjusting for other influ-
ences.  Given the lack of evidence in the literature of improved 
implant survival with these implant options, we question their 
use in routine primary THR.
Supplementary data
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